http://fortune.com/2018/12/07/africa-congo-ebola-outbreak-2018-butembo/
... The ongoing Ebola virus outbreak in the Democratic Republic of Congo has now reached Butembo, a city of over one million residents near the Ugandan border, according to the Associated Press.
...There’s an additional cause for concern as the outbreak continues: whether the vaccine stockpile will hold up. Specifically, health experts are concerned that the reserve of an experimental vaccine will run out as the epidemic continues without any sign of abating, according to the AP.
Q. Would you stick around if you were offered the vaccine?
Yes. Long enough to get the vaccine.
Currently, of those who have received the experimental vaccine on an emergency basis, there have been zero Ebola infections, and no serious side effects noted.
Once I had gotten it, I would still GTFO of Dodge, and then hunker down somewhere behind concertina wire with clear fields of fire. Q. What are the chances that vaccinated people could inadvertently infect a loved one by accidentally bringing the virus home through poor infectious control procedures?
Exactly the same as unvaccinated people doing that. If Ebola comes in, GTFO.
Period. If you can get vaccinated first, do that. Then GTFO.
Q. Is it even possible to ramp up vaccine production to one hundred million or a billion doses? We know Ebola can produce enough virus.
No effing idea. That's a question for the bean counters at Merck, Glaxo-Smith-Klein, etc. It's mainly a question of time, resource allocation, and facilities available. Making Ebola vaccine probably means they're not making tetanus, measles, and flu shots, for example, which killed more people in the 20th century than Ebola has in all outbreaks combined. In any event, it's a months-long process, and depending on when you start, you may be too late to succeed, because you won't have enough until six months after everyone in the affected area is dead. Complicating things is that so far, the vaccine is still experimental, and only being used on humans in the affected hot zone(s), because so far, there's been no full clinical trials.
http://raconteurreport.blogspot.com/2018/12/questions-i-get-questions.html